Effects of silymarin on biochemical and oxidative stress markers in end‐stage renal disease patients undergoing peritoneal dialysis

Discussion It is concluded that silymarin could be regarded as a supplementary therapy for ESRD patients undergoing peritoneal dialysis in order to reduce complications.

Source: Hemodialysis International - April 3, 2016 Category: Hematology Authors: Omidreza Firuzi, Soraya Khajehrezaei, Shahrokh Ezzatzadegan, Maryam Nejati, Keramat‐Allah Jahanshahi, Jamshid Roozbeh Tags: Original Article Source Type: research